Last updated on August 2018

Aurinia Renal Assessments 2: Aurinia Renal Response in Lupus With Voclosporin


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Lupus Nephritis
  • Age: Between 18 - 75 Years
  • Gender: Male or Female

Inclusion Criteria:

  1. Subjects who have completed 52 weeks of treatment with study drug in the AURORA 1 study. Subjects who had a temporary interruption and successfully restarted study drug during the AURORA 1 study will be allowed with Medical Monitor approval.
  2. Women of childbearing potential must continue to use effective contraception and have a negative urine pregnancy test at Month 12.
  3. Subject is willing to continue taking oral MMF for the duration of the study.

Exclusion Criteria:

  1. Currently taking or known need for any of the medications or food items listed in Section 7.8, Prohibited Therapy and Concomitant Treatment during the study.
  2. Subjects currently requiring renal dialysis (hemodialysis or peritoneal dialysis) or expected to require dialysis during the study period.
  3. A planned kidney transplant within study treatment period.
  4. Subjects with any medical condition which, in the Investigator's judgment, may be associated with increased risk to the subject or may interfere with study assessments or outcomes.
  5. Subjects who are pregnant, breast feeding or, if of childbearing potential, not using adequate contraceptive precautions.
  6. Vaccines using live organisms, virus or bacterial, while taking the study treatment.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.